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Due to the digestible refractory and absorbable structures of bioactive peptides (BPs),
they could induce notable biological impacts on the living organism. In this regard,
the current study was devoted to providing an overview regarding the available meth-
ods for BPs generation by the aid of a systematic review conducted on the published
articles up to April 2019. In this context, the PubMed and Scopus databases were
screened to retrieve the related publications. According to the results, although the
characterization of BPs mainly has been performed using enzymatic and microbial
in-vitro methods, they cannot be considered as suitable techniques for further stim-
ulation of digestion in the gastrointestinal tract. Therefore, new approaches for both
in-vivo and in-silico methods for BPs identification should be developed to overcome
the obstacles that belonged to the current methods. The purpose of this review was to
compile the recent analytical methods applied for studying various aspects of food-
derived biopeptides, and emphasizing generation at in vitro, in vivo, and in silico.
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2 A COMPREHENSIVE SYSTEMATIC REVIEW…
1 INTRODUCTION
Bioactive peptides (BPs) similar to digestion refractory
and absorbable peptides can induce potentially biological
functions (Chakrabarti, Guha, & Majumder, 2018; Sultan,
Huma, Butt, Aleem, & Abbas, 2018), while the beneficial
effects of BPs were well demonstrated (El-Fattah, Sakr, El-
Dieb, & Elkashef, 2017; Barati et al., 2017; Orona-Tamayo,
Valverde, & Paredes-Lopez, 2019) such as anticancer (Díaz-
Gómez, Castorena-Torres, Preciado-Ortiz, & García-Lara,
2017), antihypertensive (Aluko, 2015; Bhat, Kumar, & Bhat,
2017), antimicrobial (Miao et al., 2016), cholesterol lower-
ing (Nagaoka, 2019), and antidiabetics properties (Admassu,
Gasmalla, Yang, & Zhao, 2018). Although some BPs freely
exist in their natural form, most of them are known to be
released from the main proteins through enzymatic or micro-
bial digestions (Sánchez & Vázquez, 2017). Currently, more
than 3,000 different BP have been reported in BIOPEP-UMW
database. BPs are organic compounds formed by amino acids
(AAs) joined by peptide bonds. The AA sequence determines
the function of the BPs, once at the time that the peptides are
released from the parent protein where they are encrypted.
Many BPs share some structural features including a pep-
tide residue length between 2 to 20 AAs, and the presence
of hydrophobic AAs in addition to arginine, lysine, or proline
residues (Sánchez & Vázquez, 2017).
In vitro conditions were used in most of the previous studies
to characterize the BPs. In this regard, the enzymatic hydrol-
ysis or fermentation of food proteins are the two other com-
NOMENCLATURE: AAs, Amino acids; ABTS,
2,2′-Azino-bis-3-ethylbenzothiazoline-6-sulfonic; ACE inhibitors,
Angiotensin-converting enzyme inhibitors; AISC, Aspiration of intestinal
and stomach contents; BPs, Bioactive peptides; DPP-IV, Dipeptidyl
peptidase IV; GIP, Glucose-dependent insulinotropic polypeptide; GIT,
Gastrointestinal tract; GLP-1, Glucagon-like peptide-1; HCC,
Hepatocellular carcinoma; HPLC-MALDI-TOF MS/MS, High-performance
liquid chromatography-matrix-assisted laser
desorption/ionization-time-of-flight mass spectrometry/mass spectrometry;
LC MS/MS LTQ-Orbitrap, Liquid chromatography mass spectrometry/mass
spectrometry linear trap quadropole orbitrap; LC-ESI MS/MS, Liquid
chromatography coupled with electrospray ionization mass
spectrometry/mass spectrometry; LC-ESI-QTOF-MS, Liquid
chromatography coupled with electrospray ionization quadrupole time of
flight mass spectrometry; LC-MS/MS, Liquid chromatography–mass
spectrometry/mass spectrometry; LMW peptides, Low molecular weight
peptides; MALDI-TOF/TOF, Matrix-assisted laser
desorption/ionization-time-of-flight; MRM, Multiple reaction monitoring;
MS, Mass spectrometry; NCBI, National Center for Biotechnology
Information; PAC, Postabsorption characterization; PB, Proteome based;
PRISMA, Preferred reporting items for systematic reviews and
meta-analyses; QSAR, Quantitative structure-activity relationships; RAS,
Renin–Angiotensin system; RCTs, Randomized clinical trials; RP-HPLC,
Reversed-phase high-performance liquid chromatography; SCF, Standard
curve fitting; SHR, Spontaneously hypertensive rats; SPPS, Solid-phase
peptide synthesis; SPS, Solution phase synthesis; TFA, Trifluoroacetic.
mon methods of BPs identification (X. Wang, Yu, Xing, &
Li, 2017), while at a specified temperature and pH, protein
substances are subjected to enzymatic or microbial hydrol-
ysis (Najafian & Babji, 2014; Udenigwe & Aluko, 2012).
The in vitro process for BPs isolating involves protein selec-
tion, enzymatic hydrolysis, separation, and purification, while
after the last step, the biological activity, peptide sequences,
peptide structure, and the corresponded functional properties
were determined (Daliri, Oh, & Lee, 2017). Due to digestion
or unabsorbability of the peptides through the gastrointesti-
nal tract (GIT), the in-vitro characterization of BPs could not
demonstrate their in-vivo activities.
Different GIT proteases including pepsin (EC 3.4.4.1),
trypsin (EC 3.4.21.4), chymotrypsin (EC 3.4.21.1), brush-
border, and serum peptidases can affect the peptide bonds
through endogenous cleavages, which can result in the mod-
ification of the structure and also in loss of the biological
functions. In this context, most of the entered BPs in the
duodenum and jejunum cannot be absorbed into the blood-
stream (Foltz, van der Pijl, & Duchateau, 2010). Digestion
resistance and absorbability as the two main aspects of BPs
function should be evaluated before performing further char-
acterization of BPs in the blood following food ingestion (J.
Chen et al., 2018; Herregods et al., 2011). Therefore, to solve
the abovementioned issue, some in-vivo and in-silico meth-
ods were developed for BPs production. However, each one
of the in-vivo- and in-silico-based methods poses its own
disadvantages. In this regard, the current review aimed to
provide the required insights regarding the methods of BPs
identification, by emphasizing on in-vivo- and in-silico-based
methods.
2 METHODOLOGY
The recommended guidelines for Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
were used for collecting the related data (Fakhri et al.,
2019; Khaneghah, Fakhri, & Sant’Ana, 2018) (Table 1).
In this regard, a search strategy was conducted to retrieve
the related citations considering the methods of BPs
production among some international databases such as
PubMed and Scopus with the terms of “(bioactive pep-
tide[Title/Abstract]) OR (bio-active peptide[Title/Abstract])
OR (bioactive peptide[Title/Abstract]) OR (food-derived
peptide[Title/Abstract]) OR (food-derived peptide[Title/
Abstract]) OR (food-derived bioactive peptide[Title/
Abstract]) OR (food-derived bioactive peptide[Title/
Abstract]) OR (collagen hydrolysate[Title/Abstract])” up to
April 30, 2019. Moreover, the bibliographies of retrieved
citations were cross-referenced to achieve some additional
articles. The conference proceedings, abstracts, posters, and




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A COMPREHENSIVE SYSTEMATIC REVIEW… 7
book chapters due to lack of peer review and review articles
based on the recommended criteria were also excluded
(Atamaleki et al., 2019; Fakhri et al., 2019; Khaneghah et al.,
2019; Khaneghah, Fakhri, Gahruie, Niakousari, & Sant’Ana,
2019; Khaneghah et al., 2019).
2.1 Selection of the studies, data extraction,
and management
At first, all papers were collected and then entered to end note.
After that, screening the papers was performed based on their
titles and abstracts. Consequently, full texts were reviewed
to be screened in terms of the inclusion/exclusion criteria
(Fakhri et al., 2019). The relevant data were extracted includ-
ing first author, year of publication, type of study, the pro-
posed method for BPs production, and the BPs amino acid
sequence.
2.2 Data synthesis
A narrative synthesis method was used for analyzing the data
extracted (Popay et al., 2006). The confidence in the accumu-
lated body of evidence was qualitatively assessed, but it was
not graded.
3 RESULTS
In the primary step, 17,722 articles were obtained while after
screening their title/abstract, 911 papers were included, and
after full-text evaluation, only 786 articles were included,
which can be divided into in-silico (n= 22), in-vitro (n= 728),
and in-vivo (n = 36). Each category itself has been divided
into some specific subgroups. The PRISMA flowchart dia-
gram comprehensively illustrated the included article, cate-
gories, and subgroups (Figure 1). Also, the review results have
been summarized in Tables 1 and 2.
4 DISCUSSION
After performing a systematic search on PubMed and Sco-
pus, three different methods for BPs generation were defined.
The in-vitro method including microbial and enzymatic tech-
niques and the in-vivo method including postabsorption char-
acterization (PAC), aspiration of intestinal and stomach con-
tents (AISCs), and standard curve-fitting (SCF) methods have
been used to identify the BPs. Also, over the last decade, the
in-silico method has been proposed to predict the BPs struc-
ture before performing the in-vitro or in-vivo assays. The in-




Recently, proteome based in-silico method was used to
predict new types of BPs (Liao, Jahandideh, Fan, Son, & Wu,
2018). In this approach, the sequences of the desired food
item’s major proteins are obtained from the databases such as
National Center for Biotechnology Information (NCBI) pro-
tein database (http://www.ncbi.nlm.nih.gov) (Rani, Pooja, &
Pal, 2017; Sayers et al., 2019) or UniProtKB database (https:
//www.uniprot.org) (Lin et al., 2018). UniProtKB database
contains two parts named as SwissProt (https://www.uniprot.
org/uniprot/?query) and TrEMBL (https://www.uniprot.org/
uniprot/?query=reviewed:no). After the sequence extraction,
in-silico digestion was performed by software. The Peptide-
cutter software (http://www.expasy.ch/tools/peptidecutter/),
available at ExPASy Molecular Biology Server (Gasteiger
et al., 2005), and BIOPEP-UWM ‘‘enzyme action’’ tool
(Minkiewicz, Iwaniak, & Darewicz, 2019) are mostly among
the most common software used for the in-silico digestion.
The abovementioned two types of the software comprise
a range of proteases, while some of which are not specific
to the human, and some others are from bacteria. Then,
specific enzymes or chemicals were selected, individually
or in combination, depending on the aim of research/study.
After in-silico proteolysis, the released peptides with the
reported bioactivity were identified using existing databases
such as NeuroPep (Y. Wang et al., 2015), MAHMI (Blanco-
Míguez, Gutiérrez-Jácome, Fdez-Riverola, Lourenço, &
Sánchez, 2017), BIOPEP-UWM (Minkiewicz et al., 2019),
and antihypertensive peptide database (AHTPDB) (Kumar
et al., 2015). In addition to the earlier mentioned databases,
some other databases such as PepBank (Shtatland, Guettler,
Kossodo, Pivovarov, & Weissleder, 2007), PeptideDB (http://
www.peptides.be/), BitterDB (Wiener, Shudler, Levit, & Niv,
2012), CAMP (Waghu, Barai, Gurung, & Idicula-Thomas,
2016), and APD (G. Wang, Li, & Wang, 2016) can be also
used.
BIOPEP-UWM database (Minkiewicz et al., 2019) con-
tains 3,790 known BPs with 48 biological activities. The
potential BPs prediction of the proteins was made using the
above-mentioned databases. BIOPEP-UWM not only inter-
links databases of peptide, protein, and BPs sequences, but
also aids in the prediction of allergenic peptides (Rani, Pooja,
& Pal, 2018). The other peptides were investigated for the
possibility of exhibiting the bioactivity using PeptideRanker
(Mooney, Haslam, Pollastri, & Shields, 2012). Many novel
peptides without any reported function can be achieved from
the proteins, and then PeptideRanker evaluated the likelihood
of peptide bioactivity by assigning the scores of 0 and 1,
where“0″ represents the least and “1″represents the most
likely to be BPs (Rani et al., 2017).
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Peptide sequence OR peptide
name activity Reference
AISC Calf Milk YQEPVLQPVRGPFPIIV,
DAYPSGAW, AYFYPEL,
RYLGYL
— (Yvon & Pelissier, 1987)
AISC Mini-
pigs
Milk 𝛽-casein 60 to 70, 𝛼s1-casein 66 to
74
— (Meisel & Frister, 1989)
PAC Human Milk MAIPPKKNQDK,
IAIPPKKIQDK
Antithrombotic (Chabance et al., 1995)
AISC Human Milk MAIPPKKNQDKT,
AIPPKKNQDKTE
Antithrombotic (Chabance et al., 1998)
SCF Human Sardine
muscle
Val-Tyr Antihypertensive (Matsui et al., 2002)
SCF Human Collagen Ala-Hyp, Ala-Hyp-Gly,
Pro-Hyp-Gly, Leu-Hyp,
Ile-Hyp, Phe-Hyp
— (Iwai et al., 2005)







— (Bauchart et al., 2007)
SCF Rat Milk Ile-Pro-Pro Antihypertensive (Jauhiainen et al., 2007)
SCF Human Gelatin Ala-Hyp, Leu-Hyp, Ile-Hyp,
Phe-Hyp, Pro-Hyp-Gly,
Ala-Hyp-Gly, Ser-Hyp-Gly
— (Ohara, Matsumoto, Ito,
Iwai, & Sato, 2007)
SCF Human Soy
a
Lunasin anti-inflammatory (Dia, Torres, De Lumen,
Erdman, & Gonzalez
De Mejia, 2009)




Anti-hypertensive (Iwai et al., 2009)




— (Ichikawa et al., 2010)
SCF Rat Collagen Gly-Pro-Hyp Anti-hypertensive (Watanabe-Kamiyama
et al., 2010)
SCF Rat Collagen Pro-Hyp, Hyp-Gly — (Sugihara, Inoue,
Kuwamori, &
Taniguchi, 2012)
SCF Rat Collagen Pro-Hyp — (Kawaguchi, Nanbu, &
Kurokawa, 2012)
SCF Human Elastin Pro-Gly — (Shigemura et al., 2012)
AISC Piglets Infant
formula
k-casein 155 to 161, k-casein 155
to 160, k-casein 115 to 121






— (Barbé et al., 2014)
SCF Human Collagen Hyp containing peptides — (Shigemura, Kubomura,
Sato, & Sato, 2014)
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Peptide sequence OR peptide
name activity Reference
SCF Pig Milk Ile-Pro-Pro, Leu-Pro-Pro,
Val-Pro-Pro
Antihypertensive (Ten Have, van der Pijl,
Kies, & Deutz, 2015)
SCF Human Milk Ile–Trp, Trp–Leu Antihypertensive (Kaiser et al., 2016)
SCF Human Collagen Gly-Pro-Hyp, Pro-Hyp, Hyp-Gly — (Yamamoto, Deguchi,
Onuma, Numata, &
Sakai, 2016)
SCF Mice Collagen Glu-Hyp-Gly — (Taga, Kusubata,
Ogawa-Goto, &
Hattori, 2016)
SCF Rat Collagen Gly-Pro-Hyp, Pro-Hyp — (Sontakke, Jung, Piao,
& Chung, 2016)







SCF mice Collagen Gly-Pro-Hyp, Pro-Hyp Skin health (Yazaki et al., 2017)







— (Sayd et al., 2018)
SCF Human Collagen Pro-Hyp-Gly, Pro-Hyp, Ile-Hyp,
Leu-Hyp, Hyp-Gly, Glu-Hyp,
Ala-Hyp
— (Shigemura et al., 2018)
SCF Human Collagen Cyclic Pro-Hyp — (Shigemura et al., 2018)
SCF Human Collagen Ala-Hyp-Gly, Pro-Hyp-Gly,
Ser-Hyp-Gly
— (Asai et al., 2019)
SCF Rat Collagen Gly-Pro, Pro-Hyp Skin health (Lee et al., 2019)
SCF Rat Walnut VEGNLQVLRPR,
HNLDTQTESDV
— (Xiaoyu Yang et al.,
2019)
AISC Mice Casein AVPYPQR Anticoagulant (Tu et al., 2019)





AISC, aspiration of intestinal and stomach contents method; BPs, bioactive peptides; PAC, postabsorption characterization; SCF, standard curve fitting method; A, alanine;
R, arginine; N, asparagine; D, aspartic acid; C, cysteine; E, glutamic acid; Q, glutamine; G, glycine; H, histidine; I, isoleucine; L, leucine; K, lysine; M, methionine; F,
phenylalanine; P, proline; S, serine; T, threonine; W, tryptophan; Y, tyrosine; V, valine; Phe, phenylalanine; Hyp, hydroxy prolin; Ile, isoleucine; Leu, leucine; Pro, proline;
Gly, glycine; Ala, alanine; Glu, glutamic acid; Hyp-peptides, hydroxy proline containing peptides.
aLunasin: 43-aminoacide peptide isolated from soy.
The predicted BPs should be examined in terms of the
physicochemical properties, allergenicity, and toxicity. Prot-
Param (Gasteiger et al., 2005) and ToxinPred (Gupta et al.,
2013) were used to assess the physicochemical properties
and toxicity of the peptides, respectively. For allergenicity
assessment, the peptides are usually evaluated by Allerdictor
(Dang & Lawrence, 2014) and AllerTOP (Dimitrov, Bangov,
Flower, & Doytchinova, 2014) in silico. In-silico approach
has diverse aspects in the field of BPs research, and here
we only talked about BPs production (Blanco-Míguez, Fdez-
Riverola, Lourenço, & Sánchez, 2019; Tu, Feng, et al., 2017).
Kalmykova et al. (2018) and Tu, Cheng, Lu, and Du (2018) in
two different review articles comprehensively described the
websites of databases and bioinformatics tools for in-silico
analysis of the BPs (Table 3).
After in-silico digestion and BPs mining, several parame-
ters have been used to characterize the proteins as the poten-
tial precursors of the BPs. The frequency of BPs occurrence
in a protein sequence, potential bioactivity of protein-derived
fragments, the frequency of fragments released with a given
function by selected enzymes, and the relative frequency of
fragments released with a given function by selected enzymes
were mostly used (Minkiewicz et al., 2019). The parameters
are widely described in Table 4.
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T A B L E 3 In silico tools used for discovery of bioactive peptides from food proteins
Databases and
tools Website Reference Application
UniProtKB http://www.uniprot.org/ (Lin et al., 2018) protein sequences
NCBI Protein http://www.ncbi.nlm.nih.gov/protein (Rani et al., 2017; Sayers et al.,
2019)
BIOPEP-UWM http://www.uwm.edu.pl/biochemia/ (Minkiewicz et al., 2019)
PepBank http://pepbank.mgh.harvard.edu/ (Shtatland et al., 2007)
BioPD http://biopd.bjmu.edu.cn/ (Shi et al., 2004)
SwePep http://www.swepep.org/ (Falth et al., 2006)
EROP-Moscow http://erop.inbi.ras.ru/ (Zamyatnin, Borchikov,
Vladimirov, & Voronina, 2006)
MilkAMP http://milkampdb.org/ (Théolier, Fliss, Jean, &
Hammami, 2014)
PeptideDB http://www.peptides.be/ (Wiener et al., 2012)




(Minkiewicz et al., 2019) Databases of proteolytic
enzymes and in silico
digestion platforms
PeptideCutter http://web.expasy.org/peptide_cutter/ (Gasteiger et al., 2005)
PoPS http://pops.csse.monash.edu.au/pops-
cgi/index.php
(Boyd, Pike, Rudy, Whisstock, &
Garcia de la Banda, 2005)
Enzyme
Predictor
http://bioware.ucd.ie/∼enzpred/Enzpred.php (Vijayakumar et al., 2012)




(Minkiewicz et al., 2019)
AntiBP2 http://www.imtech.res.in/raghava/antibp2/ (Lata, Mishra, & Raghava, 2010)
PeptideLocator http://bioware.ucd.ie/ (Mooney, Haslam, Holton,
Pollastri, & Shields, 2013)
ToxinPred http://www.imtech.res.in/raghava/toxinpred/ (Gupta et al., 2013) Toxicity/allergenicity
prediction
AlgPred http://www.imtech.res.in/raghava/algpred/ (Saha & Raghava, 2006)
Allerdictor http://allerdictor.vbi.vt.edu/ (Dang & Lawrence, 2014)
EPIMHC http://bio.dfci.harvard.edu/epimhc/ (Reche, Zhang, Glutting, &
Reinherz, 2005)
ProPeppe https://propepper.net/ (Juhász, Haraszi, & Maulis, 2015)
SORTALLER http://sortaller.gzhmu.edu.cn/ (Zhang et al., 2012)
Molecular docking was widely used for drug discovery.
In the research field of BPs, these models were also used
widely. Molecular docking of BPs with their targets such as
angiotensin-converting enzyme (ACE) (EC: 3.4.15.1), renin
(EC: 3.4.23.15), or dipeptidyl peptidase IV (DPP-IV) (EC:
3.4.14.5) could propose similar structures with higher effi-
cacy and affinity to their targets (Tu, Cheng, et al., 2018; Tu,
Wang, et al., 2018). Novel designed peptides of sequences
Thr-Ala-Trp, Val-Lys-Trp, Lys-Tyr-Trp, and Tyr-Ala-Trp were
derived from the peptides Thr-Ala-Tyr, Tyr-Ala, Lys-Tyr, and
Val-Lys that were identified from a hydrolysate of oyster,
and increased the peptides potency compared to their corre-
sponding parental fragments (Xie, Kim, Ha, Choung, & Choi,
2014).
Although in-silico method is considered as easy and
cost-saving for identification of BPs, it should be validated
by in-vitro or in-vivo methods. Majumder et al. (2010) in
an in-silico approach predicted Ile-Arg-Tyr, Leu-Lys-Pro,
and Ile-Gln-Tyr as potent ACE inhibitors originated from
the egg proteins. Surprisingly, after pretreatment of the
protein by reducing the agents or sonication and in-vitro
digestion with pepsin and thermolysin, Ile-Arg-Tyr-Cys-Thr,
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T A B L E 4 The parameters characterizing proteins as potential precursors of BPs
Parameter Formula Reference
The frequency of BPs




a: the number of fragments with a given activity; N: The
number of amino acid residues
(Minkiewicz, Dziuba, &
Michalska, 2011)











ai: the number of bioactive fragment in a protein sequence.
EC50i: the concentration of the BP corresponding to its
half-maximal activity.
IC50i: the concentration of the BP corresponding to
half-maximal inhibition.
N: the number of AA residues
(Minkiewicz et al.,
2011)
The frequency of release of
BPs with a given activity




d: the number of peptides with a given activity (e.g., ACE
inhibitors) released by a given enzyme.N: The number of
amino acid residues in protein
(Minkiewicz et al.,
2019)
The relative frequency of
release of fragments with






Abbreviation: BPs, bioactive peptides.
Leu-Lys-Pro-Ile, and Ile-Gln-Tyr-Cys-Ala were character-
ized as the ACE inhibitors. Although the sequences achieved
from in-silico and in-vitro assays were not thoroughly
similar, the characterized BPs contained the sequences of the
predicted peptides (Majumder & Wu, 2010).
Dietary proteins through GIT loss most of their secondary,
tertiary, and quaternary structures, but, some features of sec-
ondary structures such as disulfide bonds could not be lost
easily. Thus, during in-silico BP mining, disulfide bonds
should not be forgotten. Disregarding disulfide bond during
generation of BP using in-silico method is the most impor-
tant challenge for this method. The proteome-based method
uses primary structure of a protein for generation of BP, while
disulfide bond and other posttranslational modification do not
consider in primary structure. This challenge could be solved
easily, if the peptides that have AAs involved to a disulfide
bond be linked together. Therefore, solving this challenge can
yield BPs with new structures.
4.1.2 Genome-based method
Each organism contains several types of proteins; therefore,
it is virtually impossible to detect and enter all of these pro-
teins in the proteome-based method. For that reason, the
genome-based method was introduced to comprehensively
predict the BPs found in each organism/food item. Anek-
thanakul, Hongsthong, Senachak, and Ruengjitchatchawalya
(2018) designed an in silico digestion-based platform to assist
the BPs prediction from a genome-wide database.
The common steps in the genome-based method are quite
similar to the proteome-based except one, the first step, as pro-
tein selection. In the previous method, protein selection was
manually done and based on the literature review, while in
the genome-based method, the whole organism genome was
entered as a template for whole proteome prediction. After the
prediction of the whole proteome by in-silico genome trans-
lation, BPs discovery was made, as it was mentioned earlier
(Anekthanakul et al., 2018).
In-silico approach for BPs characterization could help
researchers to identify the importance of each digestive
enzyme in the digestion process, when combined with in-
vivo and in-vitro methods. Actually, coupling in-silico meth-
ods with in-vitro and in-vivo models have importance from
two aspects as follows, as determining the importance role of
each digestive enzyme in the digestion process. The studies
used in in-silico methods are summarized in Table 2.
4.2 In-vitro methods
In most studies, BPs have been characterized using in vitro
models, which are based on the simulated digestion of food
extracts by digesting with the gut simulant enzymes or micro-
bial approach. There are several methods for in vitro digestion
of food including static and dynamic methods. These meth-
ods were designed to simulate the physiological conditions of
the upper GIT including the mouth, stomach, and small intes-
tine (Minekus et al., 2014). Hence, due to the need for harmo-
nization of the digestive conditions, the INFOGEST interna-
tional network (www.cost-infogest.eu) was established by the
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specialized experts from over 35 different countries. One of
the main tasks of this network was establishing international
consensus on the effective parameters for simulating in vitro
static digestion for food (Brodkorb et al., 2019).
4.2.1 Enzymatic methods
In this process, at an optimized temperature and pH, the
protein materials were subjected to enzymatic hydrolysis.
The enzymatic hydrolysis for producing the BPs has prior-
ity to microbial fermentation, due to the ease of scalability,
predictability, and the short reaction time (Cian, Martínez-
Augustin, & Drago, 2012). In this regard, to obtain the pep-
tide sequences, various proteolytic enzymes were used to
hydrolyze the protein (Mazorra-Manzano, Ramírez-Suarez, &
Yada, 2018). However, to incorporate the enzyme into the iso-
lated protein for hydrolysis, the enzyme activity temperature
and optimal pH should be adjusted (Cao et al., 2017; Gibbs,
Zougman, Masse, & Mulligan, 2004; Hernández-Ledesma,
Quirós, Amigo, & Recio, 2007; Mohtar Wan, Hamid, Abd-
Aziz, Muhamad & Saari, 2014).
Even though no special proteolytic enzymes are still
recognized for the production of specific BPs in any type of
food, subtilisin hydrolysis seems to be the best method for
producing the low molecular weight (LMW) peptides, while
some of them are bioactive (Khiari, Ndagijimana, & Betti,
2014). The proportion of enzyme and substrate is considered
to be an important factor for obtaining a good level of hydrol-
ysis. In this context, the peptides’ orders and their biological
activities can be correlated with the kind of enzyme used
(Alu’datt et al., 2012; X. Wang, Dong, Li, Han, & Su, 2017),
while the efficiency of the hydrolytic process may be affected
by the produced protons, which were freed during the process
of proteolysis resulting in the changes in the pH of the
medium. Nevertheless, the fluctuation of pH can be modified
by adding acid or alkali solutions; adjusting with alkali usu-
ally has some consequences in highly salted concentrations
in the hydrolysates. Therefore, it can be recommended that
the proteolysis should be performed in a suitable buffer
(Wattanasiritham, Theerakulkait, Wickramasekara, Maier,
& Stevens, 2016). The type of enzyme, temperature, and
optimum time for enzyme activity are three important factors
affecting the type of peptide produced from the protein
hydrolysis (Lafarga & Hayes, 2017). After enzymatic hydrol-
ysis, for separation of the supernatant, the mixture should
be centrifuged that can separate the LMW peptides from the
precipitates. However, the cross-flow membrane filtration,
freeze-drying, desalting, and membrane ultrafiltration or
column chromatography may help peptides to be recovered
(X. Wang et al., 2017). Gel filtration, as a promising tech-
nique, can be used to quickly separate the LMW peptides,
and furthermore, isolate them according to their sizes (Zhang
et al., 2018). By solving the freeze-dried sample into a buffer
(e.g., ammonium bicarbonate), hydrolyzed products of food
protein can be prepared, following with sonication and cold
centrifugation, while the supernatant was poured through an
ultrafiltration membrane. To recover the maximum amounts
of protein, the supernatant was added to ammonium car-
bonate as a buffer, and then once more, cold centrifugation
was used to separate the supernatant. The precipitation of
the solution was collected for profile peptides identification
known as protein fraction. After the desalting of the solution,
the peptides-dried samples were solved in acetonitrile and
formic acid in deionized water (Y. Hou et al., 2014). In some
studies, trifluoroacetic (TFA, 1% v/v) was used for sample
preparation. Also, TFA was used as the mobile phase with
methanol, acetonitrile, or water (Toll, Oberacher, Swart, &
Huber, 2005). Then, reversed-phase high-performance liquid
chromatography (RP-HPLC) was used for the separation of
BPs, because of its efficiency, versatility, and automation
abilities, while this technique also offers a suitable online
coordination with mass spectrometry (MS). Several methods
have been used to determine the BPs by HPLC such as
liquid chromatography coupled with electrospray ionization
quadrupole time of flight mass spectrometry (LC-ESI-QTOF-
MS) (Babini, Tagliazucchi, Martini, Dei Più, & Gianotti,
2017), RP-HPLC-MALDI-TOF-Mass (Zhang et al., 2018),
liquid chromatography mass spectrometry/mass spectrometry
linear trap quadropole orbitrap (LC MS/MS LTQ-Orbitrap)
(J. Chen et al., 2018), LC-ESI MS/MS (Brijesha & Aparna,
2017), and high-performance liquid chromatography-matrix-
assisted laser desorption/ionization-time-of-flight mass
spectrometry/mass spectrometry (HPLC-MALDI-TOF
MS/MS) (Srinivas & Prakash, 2010). Finally, sequences of
peptides were clarified by the aid of protein search engines
such as SwePep (http://www.swepep.org), BIOPEP-UWM
(www.uwm.edu.pl/biochemia), EROP-Moscow (http://www.
erop.inbi.ras.ru/), BioPD (http://biopd.bjmu.edu.cn), Pep-
Bank (http://pepbank.mgh.harvard.edu), MASCOT (http://
www.matrixscience.com/search_intro.html), PEAKS (http://
www.bioinfor.com), and PepArML (http://peparml.
sourceforge.net) (Edwards, 2017; Fan et al., 2019; Liu
& Pischetsrieder, 2017; Nardo, Añón, & Parisi, 2018).
4.2.2 Microbial methods
In this method, bacteria or yeast were cultured on protein sub-
stances to produce the proteolytic enzymes, which cause pro-
tein hydrolysis, and furthermore result in the production of
BPs (Chaves-López et al., 2014; Rafiq, Huma, Pasha, Shahid,
& Xiao, 2017). At first, microorganisms were grown at the
appropriate temperature to enter the exponential phase in
a broth medium. Following this, the cells were collected,
washed, and then suspended in sterile distilled water contain-
ing glucose, and were then used as an initiator to inoculate a
sterilized protein substrate (Daliri et al., 2017). The bacterial
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species, protein type, and fermentation time are among the
important factors in determining the hydrolysis rate (Daliri
et al., 2017). As an example, Lb. helveticus pose the capa-
bility of producing more peptides in fermented milk, due to
its high extracellular proteinase activity (Griffiths & Tellez,
2013; Raveschot et al., 2018). Moreover, a combination of
various bacteria or yeasts can accelerate the proteolysis of
proteins. After the process of fermentation, the mixture was
centrifuged, and then the supernatant liquid was recovered
(Rizzello, Lorusso, et al., 2017). For producing smaller pep-
tide sequences, the supernatant should be hydrolyzed using
proteolytic enzymes. Alternatively, solvent extraction or other
methods were used for the recovery of the LMW peptides in
the supernatant. Accordingly, these were purified and their
AA sequences can be analyzed using MS, and then identi-
fied using protein database search programs (Babini et al.,
2017; Edwards, 2013; Liu & Pischetsrieder, 2017; Saraswathy
& Ramalingam, 2011).
4.2.3 Challenges in in-vitro-based methods of
BPs production
It is notable that in-vitro characterized BPs do not necessarily
show their activities in-vivo (Chakrabarti et al., 2018; Joel,
Sutopo, Prajitno, Su, & Hsu, 2018), and this could be due
to the digestion or unabsorbability of the peptides through
GIT. Proteins are susceptible to large levels of hydrolysis in
the GIT by the stomach, small intestinal, and brush border
peptidases. As a result, many of the produced peptides can-
not reach the absorption stage in the duodenum and jejunum
(Chanphai & Tajmir-Riahi, 2017; Foltz et al., 2010; Keller
& Layer, 2005). Therefore, despite the common use of enzy-
matic and microbial methods, these methods cannot be con-
sidered as a suitable method for simulation of digestion in the
GIT (Bohn et al., 2018; Chakrabarti et al., 2018; Joel et al.,
2018).
4.3 In-vivo methods
Production of BPs by in-vitro methods is much easier than in
vivo, because all peptides produced from in vitro method are
originated from the food; while in vivo, in addition to exoge-
nous peptides, endogenous peptides are also detected and their
separation is very difficult. Accordingly, only a few studies
have been conducted regarding the production of BPs by the
aid of in vivo technique. The studies used in-vivo methods for
BPs production and/or characterization that are demonstrated
in Table 3.
4.3.1 Aspiration of intestinal and stomach
contents method
Based on the systematic search, AISC method was used to
produce BPs, among some human studies (Boutrou et al.,
2013; Boutrou, Henry, & Sanchez-Rivera, 2015; Chabance
et al., 1998; Svedberg, de Haas, Leimenstoll, Paul, &
Teschemacher, 1985). In this context, the appearance of diges-
tion refractory peptides in the stomach and small intestine,
using gastrointestinal intubation technique, was investigated.
In this method, after an overnight fasting, a tube was passed
through the nasal cavity into the stomach and small intestine
under the fluoroscopic control for sampling gastric and intesti-
nal contents after meal ingestion. Gastric and duodenal con-
tents were aspirated following any meal ingestion in the sub-
jects who were all overnight fasting.
Then, the peptides were fractionated and sequenced using
MS (Barbé et al., 2014; Chabance et al., 1998). The duodenum
is the most important part of the intestine for digestion; there-
fore, in this method, duodenum content was mainly sampled.
By passing half an hour from eating and at different times,
samples were taken from the contents of the duodenum at
10 cm lower than pylorus and were then mixed with a pro-
tease inhibitor, homogenized, and frozen in −70 ◦C. Further-
more, they were analyzed by Liquid chromatography (LC)–
MS/ MS and/or Matrix-assisted laser desorption/ionization-
time-of-flight (MALDI-TOF/TOF), to characterize the pep-
tides throughout the digestion. Then, they were centrifuged,
and supernatants were acidified by using TFA to pH = 2,
diluted in guanidine hydrochloride 8 M 5:1 (v:v), and then
filtered with the 30 kD membrane (Goldman et al., 2007).
Guanidine hydrochloride is a strong chaotrope and consid-
ered as one of the strongest protein denaturants. Guanidine
hydrochloride allows LMW peptides (0.9 to 5 KDa) to eas-
ily filtrate through the membrane. Then, the ultrafiltrate was
desalted on a C18 cartridge before drying. Afterward, the dried
ultrafiltrate was resuspended in 0.1% TFA/water and frac-
tionated on RP-18 HPLC column. Each fraction was analyzed
using MALDI-TOF/TOF and/or LC-MS/MS (An, Bekesova,
Edwards, & Goldman, 2010; Ressom et al., 2008). To iden-
tify the peptides, all MS and/or MS/MS data were subjected
to the protein database search engines, and for each identified
peptide, a minimum score corresponding to a P-value < 0.05
was considered as a prerequisite for peptide validation corre-
sponding to an average score (Boutrou et al., 2013; Chabance
et al., 1998; Svedberg et al., 1985).
AISC method, while compared with in-vitro-based BPs
characterization, is an invasive but more realistic one, while
recognizing BPs in this technique does not actually mean to
absorb them. Additionally, the brush border peptidases and
serum peptidase cannot be identified in the aspiration method.
In fact, the AISC method does not consider the absorbability
aspect of BPs definition.
Although the AISC method cannot cover the absorbabil-
ity aspect of BPs definition, it is very suitable for evaluat-
ing the interactions of the food matrix with BPs. Few studies
have been performed regarding the effects of food matrix on
the protein’s digestion and the nature of formed peptides, and
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the results have been sometimes inconsistent (Mennella, Vis-
ciano, Napolitano, Del Castillo, & Fogliano, 2006; A. Mohan,
Udechukwu, Rajendran, & Udenigwe, 2015; Van Lancker,
Adams, & De Kimpe, 2011). Also, the chemical structure
of proteins can be accounted as an important factor to limit
or modify the access of digestive enzymes to some cleavage
sites. Also, peptides are highly reactive due to their nucle-
ophilic structure. In this regard, during digestion, they are sus-
ceptible to altering the structure and reacting with the food
matrix. The interactions can reduce the bioavailability of BPs,
and can also change their biological activities. Moreover, the
interaction of the food matrix with peptides may produce new
compounds that may be bioactive or harmful (Udenigwe &
Fogliano, 2017).
4.3.2 Standard curve-fitting method
In this method, standard solutions of the in-vitro-
characterized BPs (di or tripeptides) were purchased,
and serial dilution of various standard concentrations was
prepared. LC-MS/MS data were used for recognizing the
concentrations of the solutions to draw the standard curve,
plotting concentration on the X-axis, and performing the
assay measurement on the Y-axis. Then, a similar assessment
was done with serum samples of the unknown concentration.
Serum samples were collected before and after the food
ingestion (e.g., gelatin hydrolysate). To analyze the data,
the researcher located the measurement on the Y-axis that
corresponds to the assay measurement of the unidentified
ingredients, and traced a line to intersect the standard curve.
The attributed value on the X-axis was the level of a substance
in the unknown sample (Ichikawa et al., 2010; K. Sato, 2017;
Shigemura, Akaba, et al., 2011; Shigemura, Nakaba, et al.,
2012; Shigemura, Suzuki, Kurokawa, Sato, & Sato, 2018).
In this method, due to the specificity of the peptide that was
evaluated, multiple reaction monitoring (MRM) can be used
to increase the accuracy. Daughter ions have a high specificity
for the detection of maternal fragments; therefore, in addition
to m/z, daughter ions were targeted for identification (Freue
& Borchers, 2012).
The SCF method measured the in-vitro-characterized pep-
tides in the serum or plasma samples. After the food inges-
tion, different BPs including various molecular weights can
be found in the blood; however, this method cannot charac-
terize all of them. The SCF method was only used to iden-
tify the predetermined structures (Shigemura, Akaba, et al.,
2011; Shigemura, Iwai, et al., 2009). In fact, this method can
be regarded as a measurement method, not as a production or
characterizing method.
4.3.3 Postabsorption characterization
The blood contains a wide variety of endogenous peptides
and proteins. Hormones and globulins made up a large part of
the peptides and protein pool. Also, the peptides derived from
degradation of endogenous proteins were also added into this
pool. Therefore, blood contains various proteins in terms of
molecular weight (D’Adamo et al., 2011; Wen & Jin, 2017).
After the food ingestion, BPs were also added to the pool;
thus, mixing the endogenous and exogenous peptides made it
difficult to separate the BPs in the blood (Figure 2). In general,
a two-step method is needed for characterizing the BPs in the
blood as follows: (a) discriminating between endogenous and
exogenous peptides and (b) characterizing the exogenous
peptides.
Based on the findings, only one study was dealt with the
characterization of BPs in the blood. Accordingly, Chabance
et al. (1995) characterizedƘ-casein derived BPs in the plasma
of newborn after milk ingestion (Chabance et al., 1995). In
this study, the infants’ plasma peptide profile after milk inges-
tion was separated and then identified using HPLC, and the
profile was compared to the plasma peptide profile of the
adults of control under the fasting condition. The sequence
of the unknown peaks was achieved by Edman degradation.
The results of the unknown peaks characterization revealed
that theƘ-casein-derived BPs with sequence IAIPPKKIQDK
and MAIPPKKNQDK were absorbed into the blood after
ingestion of milk in the infants. In this method, all aspects
of BPs definition were considered; however, after this study,
no attempt has been made to produce BPs by the use of this
method. Chabance et al. (1995) performed a comprehensive
research on the postabsorption production of BPs; however,
the tools used by these researchers had no ability in character-
izing heavier peptides (Chabance et al., 1995). In the 1990s,
MS techniques were not well developed (Singhal, Kumar,
Kanaujia, & Virdi, 2015). Nowadays, due to the remarkable
progress in the mass spectroscopy field, this method has great
potential for identifying the BPs.
Studies conducted over the last 20 years have tried to char-
acterize the endogenous LMW peptides in the serum as diag-
nostic biomarkers, using MS and protein database search pro-
grams (Ai et al., 2015; An et al., 2010; Conrads et al., 2004;
Conti et al., 2016; Goldman et al., 2007; Li, Zhang, Rosen-
zweig, Wang, & Chan, 2002; Martorella & Robbins, 2007;
Ressom et al., 2008; Villanueva et al., 2004; Yin et al., 2018).
Tirumalai et al. (2003) have designed an MS method to char-
acterize the LMW peptides in the serum. In this method,
centrifugal ultrafiltration of serum was performed to elim-
inate the bulky constituent proteins leading to the enrich-
ment of the LMW proteins/ peptides. Then, the sample (LMW
serum proteome) was digested using trypsin, and after that,
it was fractionated by cation exchange chromatography, and
was finally analyzed by microcapillary reversed-phase liq-
uid chromatography coupled online with electrospray ion-
ization tandem MS. Tandem MS spectra were searched
against the human proteomic database implementation of
SEQUEST operating on a Beowulf cluster, for identifying the
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F I G U R E 1 The study selection process
Abbreviations: AISC, aspiration of intestinal and stomach content method; SCF, standard curve fitting method; PAC, postabsorbtion characterization.
peptides sequences. In this study, analysis of the tandem mass
spectra resulted in identifying over 340 human serum pep-
tides; but not even a single peptide from serum albumin was
observed (Tirumalai et al., 2003). Surprisingly, in a similar
study, An et al. (2010) reported several LMW peptides as
hepatocellular carcinoma (HCC) diagnostic biomarkers. Two
groups of serum samples were enrolled in this study as fol-
lows: the serum samples of the patients with HCC and the
healthy subjects (as control). The researchers characterized
the LMW peptides in both samples using the method that
Tirumalai et al. (2003) have designed. After that, the pro-
file of the LMW peptides in the HCC patients was com-
pared with the healthy controls. The study results served
NGFKSHALQLNNRQI, DDPDAPLQPVTPLQLFEGRRN,
VPPNNSNAAEDDLPTVELQGVVPR, and HVQPQPQP-
KPQVQLHVQSQT as diagnostic biomarkers of HCC (An
et al., 2010).
The method used in An et al. (2010) study can be consid-
ered as a good model for BPs characterization in the blood
(An et al., 2010). Determination of the LMW peptides profile
under the fasting condition (as control), and the postingestion
using MS, and intergroup comparison of both profiles can be
considered as a comprehensive method for BPs characteriza-
tion. Identifying the unknown MS peaks could be considered
as the most important step in the method. After identifying
the unknown MS peaks, the peaks should be converted to
AA sequence in-silico using protein database search programs
such as MASCOT, SEQUEST, and PepArML (Damodaran,
Wood, Nagarajan, & Rabin, 2007; Edwards, 2013; Liu
& Pischetsrieder, 2017; Saraswathy & Ramalingam, 2011)
(Figure 3).
Recognizing the food components in the blood means that
there are specific mechanisms for their absorption in the intes-
tine. The recognition of BPs in the bloodstream indicated
that they have a definite intestine absorption process (tran-
scellular or paracellular) (Räder, Reichart, Weinmüller, &
Kessler, 2018; Shen & Matsui, 2017, 2019; Vorherr, Lewis,
Berghausen, Desrayaud, & Schaefer, 2018; Xu, Hong, Wu,
& Yan, 2019), and this specific absorption way can help
researchers in producing oral peptide drugs (Cammisotto
et al., 2010; Villaseñor, Lampe, Schwaninger, & Collin,
2019). Bioinformatics simulation of BPs absorption is cru-
cial to recover the peptides, which their absorption has already
been proved (Hu & Smith, 2019; Marques et al., 2018). The
BPs with high molecular weight are better for those proposed
ways and mechanisms of absorption in the process of the
newly produced peptide drugs (H. Fan, , Liao, & Wu, 2019;
Lamberti, Cascone, Iannaccone, & Titomanlio, 2012; Minhas
& Newstead, 2019); For example, when one BP including 30
AAs is identified in blood after food intake. Next, the iden-
tification of the absorption ways of this peptide in-silico and
confirming it in-vitro and in-vivo will be big achievements in
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F I G U R E 2 The blood peptide profile under fasting condition and in the postabsorptive phase. (a) The blood peptide profile under fasting
condition. (b) The blood peptide profile in the postabsorptive phase. The blood contains various peptides in terms of molecular weight. After food
ingestion, BPs are also added to the pool
the production of oral peptide drugs. Coupling the Glucagon
with 29 AAs and insulin with 51 AAs with absorption mech-
anisms of the BPs will be great assistance in the drug deliv-
ery science and technology. For this purpose, the PAC of BPs
should widely be developed.
4.4 Challenges in BPs separation and
characterization
BPs are usually separated using different chromatographic
techniques. There are some problems and limitations for
the separation and characterization of the BPs. Since BPs
are often in very short sequences (two to six AAs); this
is an important challenge for current proteomic techniques
(Piovesana et al., 2018). Small peptides may not be suitable for
the detection of MS, because they are often singly charged and
it is very difficult to obtain the appropriate fragment (Nongo-
nierma & FitzGerald, 2017). In addition, the classic database
search method is not compatible in this case. Peptides of less
than six AAs are not usually detectable in bioinformatics soft-
ware with a high confidence, and the peptide is likely to be
found in a whole range of protein sequences leading to a
redundancy in MS/MS database search methods. The prob-
lem is more about peptides ACE-inhibitors, because they are
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F I G U R E 3 An illustration for BPs characterization in the blood. In this figure, three steps are shown: 1—Mass spectrometry: Serum peptides
under fasting condition (as control) and in the postabsorbtion phase are analyzed by using MS separately. Mass spectrometry chromatograms show
serum peptides mass. 2—Unknown peak selection: The peaks that appear after food ingestion are called unknown peaks. 3—Unknown peak
characterization: characterization of unknown peptide peaks using protein database search programs
Abbreviations: LMW, low molecular weight; BPs, bioactive peptide.
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usually small peptides. It should be noted that small peptides
require some specific separation techniques. The classical RP-
HPLC and SEC methods used to separate BPs are not suitable
for small peptides (Li-Chan, 2015).
Another issue in purification and fractionation of peptides
is related to the scale. Peptide properties such as molecular
mass, net charge, and hydrophobicity are important parame-
ters that must be considered during the separation processes
in industrial application (Rizzello, Tagliazucchi, et al., 2016).
Solid-phase methods and techniques such as RP-HPLC are the
most commonly used methods in the studies (laboratory scale)
that allow the production of peptides up to 5 kg per year, but
the problem is that they are expensive. Although peptides syn-
thesized by chemical methods are cheaper, but they have no
food application, and are also more commonly used as drugs
and diagnostic targets (Lafarga & Hayes, 2017).
When MS is used to identify the peptides in complex matri-
ces, protein databases are the most common methods for
matching these spectra. This method is successful when the
target protein database is complete, and the cleavage created
by the digestive enzymes is completely clear. If the target pro-
tein database is not fully identified and the digestive enzyme is
not site-specific, their identification process requires a longer
time and the probability of identifying the related peptides is
reducing (Armengaud et al., 2014; Mohayeji et al., 2014).
4.5 BPs function and methods of BPs
function assessment
4.5.1 BPs function
In recent years, the major focus on BPs was on the more
evidence-based wider use of them on specific health or med-
ical benefits, including blood pressure lowering (BP), lipid
lowering, anticancer, immune modulatory, antimicrobial,
antioxidant, anti-inflammatory, and anticoagulation effects
(Figure 4) (Cheng, Tu, Liu, Zhao, & Du, 2019; Park &
Nam, 2015; Rutherfurd-Markwick, 2012; Yu, Wang, Zhang,
& Fan, 2016). The types of enzymes and protein substrates
are key factors in producing various BPs with dedicated func-
tions. Recent publications reported the correlation of the pep-
tides’ functions with their AA sequences widely. Each AA
in sequence fragments has its own properties in terms of
hydrophilicity/hydrophobicity, size, polar, and charge (Qin
et al., 2019).
Antihypertensive and antithrombotic peptides
To date, food-derived ACE inhibitors such as some BPs have
attracted attention from a wide range of sources. According
to previous reports, BPs in milk, soybean, animal muscle,
wheat germ proteins, and fish proteins can be considered as an
ACE inhibitors (Tu, Liu, et al., 2018; Tu, Wang, et al., 2018).
Nasri et al. (2012) isolated and identified the four novel BPs
sequences with high anticoagulant activity from goby muscle
protein. Moreover, Khiari, Rico, Martin-Diana, & Barry-Ryan
(2014) reported that bioactive gelatin peptides from mackerel
(Scomber scombrus) skin hydrolysates can be able to inhibit
platelet aggregation significantly and may be considered valu-
able due to its antithrombotic activity.
It has been known that ACE-inhibitory BPs are short in
length, and their potency is strongly affected by C-terminal
residue. Regarding dipeptides, hydrophobic side chains such
as Phe, Trp, and Tyr were also preferred AA residues with
bulky side chain (Pangestuti & Kim, 2017). Also, for tripep-
tides, the aromatic AAs are the most favorable residues for the
C-terminal, for the middle position of them positively charged
AAs preferred, and hydrophobic residues were favored for
the N-terminus (Wu, Aluko, & Nakai, 2006). The bioinfor-
matics analysis, quantitative structure-activity relationships
(QSAR) model and molecular docking, revealed that the high-
est ACEI dipeptides had Trp (Lys-Trp and Val-Trp) at their C-
terminus (Manzanares, Gandía, Garrigues, & Marcos, 2019).
In this regard, among tripeptides, the highest potent ACE
inhibitory properties of biological tripeptides correlated with
having Pro (Met-Lys-Pro, Phe-Ala-Pro, Val-Ala-Pro, Ile-Pro-
Pro, Val-Pro-Pro, and Lys-Arg-Pro) or Tyr (Ile-Val-Tyr) at
the C-terminus. Regarding the regulation through the renin–
angiotensin system (RAS) by BPs, it is known relevance
of Trp in the sequences of these peptides. The most potent
peptides (Ile-Trp, Leu-Trp, Val-Trp, and Ala-Trp) with renin
inhibitory properties all possess Trp at the C-terminus and
branched chain aliphatic residues, L or I, at the N-terminus
(Udenigwe & Aluko, 2012). Arg-Tyr-Leu-Pro, Tyr-Thr-Ala-
Trp-Val-Pro, and Tyr-Arg-Ala-Trp-Val-Leu were revealed as
a novel inhibitory structure against both renin and ACE. For
dual inhibition effect (renin and ACE inhibition), it was estab-
lished that longer peptides such as tetrapeptides and pentapep-
tides are better candidates versus short peptides such as dipep-
tides (J.-H. Wang et al., 2013). Captopril was known as the
first orally active ACE inhibitor that designed based on the
results obtained from interaction among ACE, Ala-Pro, and
Phe-Ala-Pro peptides (Cushman, Cheung, Sabo, & Ondetti,
1977).
Antidiabetic peptides
The most aimed target for antidiabetic BPs is the inhibition
of metabolic enzymes involved in the regulation of serum
glucose, including DPP-IV (EC: 3.4.14.5), 𝛼-amylase (EC:
3.2.1.1), and 𝛼-glucosidase (EC: 3.2.1.20). The aromatic AAs
with polar side chain and proline at the N-terminus (such
as Trp-Pro but also Tyr-Pro) were detected in the sequence
alignment of different DPP-IV inhibitory BPs (Nongonierma
& FitzGerald, 2014). DPP-IV is a ubiquitous enzyme that
causes a loss in glucagon-like peptide-1 (GLP-1) and glucose-
dependent insulinotropic polypeptide (GIP) activity through
their cleave and inactivation. Regarding the inhibition of
𝛼-glucosidase, it has been made clear that the sequences
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Abbreviations: BPs, bioactive peptides; ACE, angiotensin converting enzyme; DPP ІV, dipeptidyl peptidase ІV; ROS, reactive oxygen species; RNS,
reactive nitrogen species.
including three to six AA residues with either Ser, The, Tyr,
Lys, or Arg at the N-terminus and a Pro residue in the vicin-
ity of the C-terminal with residues Met or Ala occupying
the C-terminal position are necessary (M. A. Ibrahim, Bester,
Neitz, & Gaspar, 2018). Ala-Lys-Ser-Pro-Leu-Phe, Gln-Thr-
Pro-Phe, Phe-Glu-Glu-Leu-Asn, and Leu-Ser-Lys-Ser-Val-
Leu were known as multifunctional antidiabetic BPs due to
their potential inhibitory activities of DPP-IV, 𝛼-amylase,
and 𝛼-glucosidase. These peptides inhibited the mentioned
enzymes through hydrogen bonds, polar, and hydrophobic
interactions (Mojica & de Mejía, 2016).
Antioxidant peptides
According to pioneering studies, exogenous antioxidants like
some BPs are necessary to maintain the oxidative and antiox-
idative balance in biological systems (Ye et al., 2018). It is
generally accepted that several AAs such as Tyr, Met, His,
Lys, and Trp when incorporated into peptides may have poten-
tial health benefits with high activity and easy absorption
without any side effects (Tu, Cheng, et al., 2018). Apart from
this agreement, the lack of full knowledge regarding the struc-
ture activity of antioxidant peptides and their mechanism of
actions as well the lack of a standardized methodology for
evaluating the in vitro antioxidant activity for comparison var-
ious results from different laboratories are major hampers in
this realm (Zou, He, Li, Tang, & Xia, 2016).
Anticancer peptides
A growing body of biological peptides from natural animal
sources is being considered as novel drug candidates for can-
cer therapeutic applications. Although some major mecha-
nisms for the anticancer effects of the BPs have been pro-
posed, the precise mechanism of their anticancer effects is
still controversial. In general, the anticancer effect of BPs may
be associated with some membrane or nonmembrane mecha-
nisms (X. Wang et al., 2017; Zhou et al., 2017). The plasma
membrane contains two phospholipid layers as a selective
barrier that are essential to cell survival and function. Sev-
eral studies have shown that antimicrobial peptides destroy
the function of cancer cells by disrupting the cell mem-
brane (Lohner & Hilpert, 2016; L. Wang, Dong, Li, Han,
& Su, 2017). Specifically, the peptides target is negatively
charged membrane components including phosphatidylserin,
sialic acid, and heparan sulfate (Riedl et al., 2011). In fact, the
BPs distinguish between cancer and noncancer cells by tar-
geting the negatively charged lipid layer on the outer leaflet
of the cancer cell membrane (Riedl et al., 2015). The effect
of each peptide on the membrane activity of the cancer cells
depends on the characteristics of the BP and the target mem-
brane antibody. Membrane dysfunction occurs in a variety of
ways including lipid pore formation, membrane layer thin-
ning, membrane dissolution, or lipid–peptide domain for-
mation (Rashid, Veleba, & Kline, 2016). In addition to
20 A COMPREHENSIVE SYSTEMATIC REVIEW…
disrupting the plasma membrane, some anticancer peptides
induce apoptosis through the mitochondrial pathway (Whelan
et al., 2012). Therefore, the apoptosis induced by mitochon-
drial membrane dysfunction plays an important role in the
treatment of cancer (Mulder, Lima, Miranda, Dias, & Franco,
2013). Therapeutic BPs have several significant advantages
such as small size, minimal drug-drug interaction, high abil-
ity to penetrate the cell membranes, easy synthesis, and min-
imum toxic side effects. However, metabolic instability, poor
oral bioavailability, and rapid clearance are some disadvan-
tages of therapeutic BPs in this regard (Marqus, Pirogova, &
Piva, 2017).
Basic studies and clinical findings
Many in-vivo (M. Sato et al., 2002; Yasufuku et al., 2001)
and randomized clinical trials (RCTs) (Benito-Ruiz et al.,
2009; Bruyere et al., 2012; Trc & Bohmova, 2011) evalu-
ated the oral administration of BPs and BP-contained pro-
teins on health outcomes. Sato et al. in an in-vitro study char-
acterized Wakame-derived BPs with ACE inhibitory func-
tion. The in-vitro part of the Sato study represented Val-
Tyr, Ile-Tyr, Ala-Trp, Phe-Tyr, Val-Trp, Ile-Trp, and Leu-Trp
as antihypertensive BPs. In the in-vivo part, the researchers
evaluated the effect of oral administration of the peptides
with 1 mg/kg on blood pressure in spontaneously hyper-
tensive rats (SHRs). The in-vivo results revealed that Val-
Tyr, Ile-Tyr, Phe-Tyr, and Ile-Trp significantly decrease sys-
tolic blood pressure in the rats (M. Sato et al., 2002). In
a similar study, Nii et al. reported antihypertensive effects
of shrimp-derived BPs, Val-Trp-Tyr-His-Thr, and Val-Trp in
SHR (Nii, Fukuta, Yoshimoto, Sakai, & Ogawa, 2008). The
mentioned studies used purified BPs for application in in-vivo,
while some experimental studies used BP-contained proteins.
Yasufuku et al. (2001) examined the effect of oral adminis-
tration of collagen V on lung allograft rejection and found
that the treatment reduces the allograft rejection by induc-
tion of oral tolerance. In a similar study, Roldán et al. revealed
that oral administration of glycomacropeptide, a milk-derived
BP with 64 residues, prevents immune response in asthma
and progression of the disease (Roldan, Jimenez, Cervantes-
Garcia, Marin, & Salinas, 2016). Both of the studies used BP-
contained proteins, and oral tolerance induction is the primary
outcome for their results. Many experimental studies similar
to Roldán et al. (2016) and Yasufuku et al. (2001) were per-
formed and within their framework concluded that oral tol-
erance is the main mechanism for the therapeutic effects of
BP-contained proteins (Chen, Bao, Wang, Xie, & Wu, 2012;
Cui et al., 2017; Moronta, Smaldini, Fossati, Añon, & Docena,
2016; Nishikimi et al., 2018; Xi et al., 2009).
From the studies used BP-contained proteins, two impor-
tant points should be considered: (a) the BPs should not be
absorbed and entered into the circulation to exert their bene-
ficial effects necessarily. BPs induce oral tolerance, an anti-
inflammatory process, in the gut especially before digestion
and when they are encrypted in their parent proteins. The
gut immune system continuously samples the gut content and
almost always tolerance versus dietary proteins happen (Pabst
& Mowat, 2012) and (b) immune tolerance induction is very
beneficial for prevention and treatment of cardiovascular dis-
ease (Figure 5) (Wigren et al., 2012), but Barth et al. (2015)
in a nested case-cohort study revealed that factors related to
immune tolerance increase risk of some solid cancers.
Poor chemical and physical stability, short plasma half-life,
and low and variable bioavailability are crucial problems of
bioactive compounds for their application as nutraceuticals or
functional foods. The stability of BPs through GITcould be
evaluated by finding trypsin, chymotrypsin, and pepsin cut-
ting position (Manzanares et al., 2019). Commercially syn-
thesis of BPs for management and treatment of hypertension,
diabetes, and other chronic disease may not be cost/benefit
effective. Nevertheless, structure-activity studies are prefer-
able for designing the important drugs based on the results
obtained from the BPs (Cushman et al., 1977).
4.5.2 Methods of BP function assessment
In this systematic review, we comprehensively assessed the
methods of BP generation. BPs have wide and different func-
tions, and methods of function assessment for BPs are all
different from methods of BP generation. In brief, function
assessment for BPs could be performed by different methods
including: (a) prediction of BPs function by QSAR models,
(b) enzyme inhibitory function assessment, (c) antimicrobial
and antioxidant capacity assessment, and (d) anticancer activ-
ity assessment.
In biological and chemical sciences, QSAR models are
used as classification models. First of all, in these models, a
supposed association between two factors in chemicals data
set including biological activity and chemical structures is
summarized. On the other hand, about new chemical sub-
stances, QSAR models could predict activities. In fact, QSAR
models let us predict the function of a BP based on similar-
ity with prestructured library. Although in-silico prediction
of BPs function is cost-effective and time-saving, the role
achieved in-silico should be confirmed in-vitro and in-vivo
(Deng et al., 2019).
The enzyme inhibitory function of BPs is an in-vitro
method and is based on the ability of a given enzyme
to hydrolyze the internally quenched fluorescent substrate,
for instance, o-aminobenzoylglycyl-p-nitro-l-phenylalanyl-L-
proline for ACE (Sentandreu & Toldra, 2006) and Gly-Pro
p-nitroanilide for DPP-IV (Beckenkamp et al., 2015), in the
presence of the BP. After incubation of a BP with a given
enzyme in the presence of the internally quenched fluores-
cent substrate, generation of fluorescence is measured and
enzyme inhibition is expressed as percentage (H. R. Ibrahim,
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F I G U R E 5 The effects of BP-contained proteins on cardiovascular health. 1—Sampling of dietary protein content of the intestine by dendritic
cells located in the gut. 2—Dendritic cells that activated by BP-contained proteins interact with immature immune cells; 3—Immature immune cells
after interaction with activated dendritic cells turn into a kind of mature immune cells called immune tolerance cells or regulatory T cells.
4—Migration of immune tolerance cells to atherosclerotic plaques (cardiovascular endothelium) and interaction with inflammatory cells (foam cells)
caused cardiovascular disease. 5— Suppression of foam cells function by immune tolerance cells and improvement of endothelium
Abbreviations: IL-10, interleukin 10; TGF-beta, transforming growth factor-beta.
Ahmed, & Miyata, 2017). On the other hand, By means of
disc diffusion assay, BPs antibacterial activity is examined.
In the nutrient broth, activation of indicator microorganisms
is happen. On the indicator strain that is prepared freshly,
sample aliquots are spotted. Then, at the optimum temper-
ature, incubation of plates is done. Diameters of zone in
which growth is inhibited are measured subsequently. Then
the “inhibition zones” are reported. In this regard, sterilized
water and streptomycin are negative and positive controls,
respectively (N. M. Mohan et al., 2019; Offret, Fliss, Bazinet,
Marette, & Beaulieu, 2019). In a different method, antioxi-
dant capacity of BPs is assessed. Method of 2,2′-Azino-bis-
3-ethylbenzothiazoline-6-sulfonic (ABTS) assay is a common
used assay in assessment of antioxidant capacity. Basis of
this method is as follows: Reduction in ABTS acid cations
through the antioxidant peptides addition leads to decoloriza-
tion of reagent. This is spectrophotometrically measureable
and depends on some factors such as reaction time, concen-
tration, and type of antioxidant (Aloglu & Oner, 2011; Ayala-
Niño et al., 2019). Other methods for measuring of antioxidant
activity are included oxygen radical absorbance capacity, total
radical trapping antioxidant potential, 2,2 diphenyl-1 picryl-
hydrazyl, ferric reducing antioxidant power, enhanced chemi-
luminesence, and electron spin resonance (Power, Jakeman,
& FitzGerald, 2013).
For anticancer activity assessment, cancer cell line should
be exposed to BPs and after exposure, cell growth and apop-
tosis should be evaluated by proliferation assays and flow
cytometry, and if a BP insert apoptosis and reduce cell growth
then, by evaluation of intracellular signals using real-time
polymerase chain reaction (PCR) and western blot, the exact
mechanism could be clarified (Ma et al., 2015; Su, Shi, Yan,
Xi, & Su, 2015). For hypolipidemic function assessment,
a protocol like this method should be performed, but the
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difference is that BPs are mostly exposed to HepG2 cell line,
human liver cancer cell line (Inoue et al., 2011).
There are many methods for assessment of BPs function,
and here, we described some more common methods, briefly;
therefore, “the methods of BP function assessment” could be
a good topic for preparation of a systematic review. A most
important point about function assessment is that any function
obtained in-vitro or in-silico should be confirmed in-vivo.
4.6 Nonfood derived BPs
In the current systematic review, however, the food-derived
BPs were discussed, there are many BPs with nonfood sources
that may originate from nonnutritional origins even danger-
ous sources such as the venom or may obtained by the aid
of some bioinformatics assays. In this regard, the anticoagu-
lant BPs, nonfood derived BPs, have been investigated more
than food-derived BPs, while the most important source of
nonfood derived BPs is the venom of different animals such
as snake, frog, and bee (Pennington, Czerwinski, & Norton,
2018). Venoms from different animals such as snake in low
doses have been used by some traditional remedies for treating
different disease such as cancers, gastrointestinal disease, and
arthritis (Casewell et al., 2014; Pennington et al., 2018). While
the venom is a heterogeneous mixture of organic molecules,
peptides, enzymes, and inorganic salts, the venom-derived
BPs should be purified as single peptides, to be used as the
drugs.
As mentioned above, most venoms are a mixture of pep-
tides, proteins, enzymes, organic, and inorganic materials.
Due to technology progresses over the past decades, it became
easier to separate and purified venoms, especially as peptides
and proteins. For the first time in 1980s, classical chromatog-
raphy was used to purify the venom content and subsequently
sequenced the fractions using the Edman degradation or mass-
spectroscopic techniques. Due to the presence of disulfide
bonds, many of nonfood derived BPs are highly structured
(Petras et al., 2019). With advancement in nuclear magnetic
resonance instrumentation, three-dimensional structures of
the venom components have been obtained (Ramirez, Shekht-
man, & Pande, 2018). Unlike food-derived BPs, for separa-
tion, identification, and characterization of nonfood derived
BPs, no digestion is needed (Mourão & Schwartz, 2013).
Previously, intracerebroventricular injection of nonfood
derived BPs into mice was used for the assessment of
peptide’s function (El Hidan et al., 2016). Also, heterolo-
gous expression of specific ion channels in eukaryotic cells
by microinjection of cDNA has been applied to determine the
ion channel blocking function of nonfood-derived BPs (Pen-
nington et al., 2018). Another method for function assess-
ment of nonfood-derived BPs is fluorometric substrate-based
assays that are used for identifying inhibitors of biological
fluid enzymes, especially blood-clotting enzymes (van der
Wel et al., 2015). Other assays, such as the surface plas-
mon resonance (Choudhury, Konwar, Kaur, Doley, & Mon-
dal, 2018) and fluorescence imaging plate reader (Jin et al.,
2019), have significantly accelerated BPs identification.
Although the nonfood-derived BPs have higher affinity
to their target and effectively exert their biological func-
tion in comparison with food derived BPs, the sources of
nonfood derived BPs are rare and very expensive (Estevao-
Costa, Sanz-Soler, Johanningmeier, & Eble, 2018). Also, the
nonfood-derived BPs could not be administered orally, due
to instability of their structure through GIT. As mentioned
about food-derived BPs, identification of biologically active
fragments is performed after in-silico, in-vitro, or in-vivo
digestion, while, for nonfood-derived peptides, digestion only
destructs the active fragments (Mourão & Schwartz, 2013).
It should be noted that in heavy protein sequencing, diges-
tion is used to reduce protein size to allow for more accurate
sequencing (Lomazi, Nishiduka, Silva, & Tashima, 2018).
4.7 BP synthesis
The methods described in the current investigation are strictly
for BP identification, once a peptide sequence with desirable
bioactive properties has been identified, and then, it would
be prepared through a synthetic technique. The techniques for
peptide/protein synthesis could be divided into two subgroups
including chemical and chemoselective Ligation methods (W.
Hou, Zhang, & Liu, 2017). Chemoselective ligation tech-
niques are usually used for protein synthesis (Tiefenbrunn &
Dawson, 2010), while chemical methods can be used for the
synthesis of BPs (Zhu, He, & Hou, 2019).
4.7.1 Chemical methods for BP synthesis
There are two main chemical methods for producing peptides
in industrial/laboratory scales including solution phase syn-
thesis (SPS) and solid-phase peptide synthesis (SPPS) (Jara-
dat, 2018). In the classical SPS, the method is based on sin-
gle AA pairing in solution, while for producing long peptide,
the fragment condensation method is used. First, short seg-
ments of the identified peptide are synthesized. Then, these
fragments are paired together and a long peptide is formed.
SPS method can be nominated as in a simple and inexpen-
sive way, while purification of intermediate products can be
archived at the high level of purity. On the other hand, the dis-
advantage of the SPS technique is a long reaction time (Chan-
drudu, Simerska, & Toth, 2013).
In terms of supporting for growing peptide, the resin is used
as an anchor within the SPPS method. In this case, attachment
of C-terminus of the first AA and the resin happens. Demon-
strating both alpha-amino group (as antipolymerization agent)
and some groups on the reactive side chain, which are tem-
porary protecting the groups, is a distinctive characteristic of
the first AA. By adding subsequent AA, the protection group
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of the first AA is removed and the resin is washed before
the adding the subsequent AA to the chain. This process is
repeating until the completion of peptide sequence, and then,
the desired peptide is dissociated from the resin (Chandrudu
et al., 2013); For instance, two protecting groups includ-
ing tert-butyloxycarbonyl (Boc) and fluorenylmethyloxycar-
bonyl (Fmoc) are often used (Behrendt, White, & Offer, 2016;
Raz et al., 2016). Development of microwave-assisted SPPS
leads to a notable improvement in SPPS synthesis, especially
in long peptides synthesizing. However, the high efficacy
in peptide production and low degrees of racemization can
be achieved by the aid of the microwave radiance (Vanier,
2013). Also, this technique has some limitations including the
expense of its equipment besides the cost of resin and reagents
used in this technique (Chandrudu et al., 2013).
5 CONCLUSIONS AND FUTURE
PERSPECTIVES
Three different models of BPs production were assessed by
the aid of a systematic review. The in-vitro model, includ-
ing microbial and enzymatic methods and the in-vivo model,
including PAC, AISC, and SCF methods, have been used for
BPs characterization. Recently, in-silico methods have also
been suggested to predict BPs. So far, characterization of
BPs has been mainly investigated by enzymatic and micro-
bial in-vitro methods; however, despite the common use of
the methods, they cannot be considered as suitable methods
for simulation of digestion in GIT. Hence, the in-vivo and in-
silico methods of BPs production were developed to solve this
issue. Although the in-vivo-based methods have their disad-
vantages, with the further advancements in the field of mass
spectroscopy and bioinformatics, the in-vivo methods gained
the opportunity to be expanded.
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